About NeoTract, Inc. NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. NeoTract is a very high achieving organization that operates under a set of standards that promote innovation, collaboration and integrity at all times. Customer focused, NeoTract employs a sales force of urology consultants, who strive to partner with our customers to improve their practices by offering access to superior state of the art healthcare.... View Article
Location: United States, California, Pleasanton
Total raised: $23.7M
Investors 3
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | CRG | crglp.com |
| - | Questa Cap... | questacapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.07.2009 | - | $23.7M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 09.02.2018 | Stanford spin-out Zenflow raises $31M to join the megamarket... | In a phone interview, Damiano said the startup “threw out a broad net” for funding and between 2015 ... | medcitynew... |
| 08.05.2015 | Medtech execs: Thinking about reimbursement early is key to ... | At a time when the regulatory barriers put up by the Food and Drug Administration seem to be easing ... | massdevice... |
| 05.09.2012 | Startup targeting enlarged prostate patients believes it can... | Founder and CEO Michael Todd won’t reveal too many details about the procedure and the device except... | medcitynew... |
| 30.07.2009 | Neotract raises $23.7M to treat urological and gynecological... | Neotract, maker of devices used to treat urological and gynecological disorders, has raised $23.73 m... | venturebea... |
| - | Stanford spin-out Zenflow raises $31M to join the megamarket... | A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Ser... | medcitynew... |
| - | Startup targeting enlarged prostate patients believes it can... | A stealth mode Simi Valley, California startup wants to disrupt the field of how benign prostatic hy... | medcitynew... |